09.30.25 -- Unlocking Method Insights For Novel Engineered AAV Capsids

Address your concerns with traditional viral vector production processes by using a scalable upstream AAV production platform solution for viral gene therapies.

Discover how a leading biopharma company boosted flexibility and quadrupled productivity by implementing a concentrated fed-batch process in a single-use facility.

Allogeneic cell therapies offer incredible promise, but scaling up PSC manufacturing presents unique challenges. Explore these hurdles along with solutions for consistent, high-quality production.

Choosing the right delivery system is a critical decision in gene therapy. We explore the advantages and challenges of today’s leading viral and non-viral vector technologies.

Explore the automated production of protein microparticles using an innovative method that offers a standardized and scalable solution for co-precipitation in biopolymer particle fabrication.

Behind every life-saving cell therapy is a complex manufacturing journey. Examine the critical role of automation in overcoming production challenges and ensuring quality.

Learn how electroporation can be used to efficiently engineer T cells for CAR T cell manufacturing workflows with piggyBac™ transposons while maintaining high viability and cell yield.

Learn how stirred-tank bioreactors overcome the scalability limitations of static culture for MSC-EV production, while Raman spectroscopy provides unprecedented real-time quality monitoring during production.

A study demonstrates consistent manufacturing of T cells across a multi-unit system, with low variability in key metrics like cell expansion and transduction efficiency.

Learn about a modular, functionally closed, end-to-end solution for the manufacture of autologous CAR T cell therapies.